All studies
RecruitingPHASE2INTERVENTIONAL

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

This study is testing a new medicine called LY3537021. Its main aim is to find out how good this medicine is at preventing and controlling the sickness (nausea) and vomiting that often happens with chemotherapy for cancer. The study will also carefully check for any side effects and make sure the treatment is safe for patients. People taking part in this study will be followed for about two months to see the full effects of the medicine. It's for adult cancer patients who are about to start certain types of chemotherapy.

At a glance

Status
Recruiting
Phase
PHASE2
Sponsor
Eli Lilly and Company
Enrolment target
204
Start
28 Nov 2025
Estimated completion
01 Feb 2027

What is this study about?

When you have chemotherapy for cancer, a common side effect is feeling sick and throwing up. This can be very unpleasant and make it hard to go about your daily life. This study is testing a new medicine, called LY3537021, to see if it can help reduce or stop these side effects. We want to understand how effective this medicine is at making patients feel better and whether it is safe to use.

During the study, some patients will receive the new medicine, while others might receive a dummy medicine (a placebo) or standard anti-sickness treatments that are already available. This helps us compare and understand the true benefits of LY3537021. We are also looking at how the new medicine works alongside your usual chemotherapy.

The information gathered from this study will help doctors decide if LY3537021 could be a good new option for people undergoing chemotherapy in the future. It’s all about finding better ways to make chemotherapy easier to cope with and improve the quality of life for cancer patients.

Key takeaways

  • Tests a new medicine (LY3537021) for chemotherapy-induced sickness.
  • Aims to improve comfort for cancer patients.
  • Compares the new medicine to existing treatments or a dummy medicine.
  • Participation lasts about two months.
  • Suitable for adults starting specific types of chemotherapy.
  • You can stop participating at any time.

Who may be eligible?

This study is looking for adults aged 18 and over who have cancer and are about to start certain types of chemotherapy for the first time. Specifically, your chemotherapy should be either AC (Adriamycin and Cyclophosphamide) or a cisplatin-based type, given as a single dose on the first day of each cycle.

There are some reasons why you might not be able to join. For example, if you have certain existing health conditions such as untreated problems with your brain (like some tumours), uncontrolled diabetes, or specific heart conditions. Also, if you already have sickness or vomiting from another cause, or if you're taking medicines that might affect sickness, you might not be suitable.

It's important that you haven't been in another medical study recently and aren't pregnant or breastfeeding, or planning to become pregnant during the study period. Your doctor will carefully check all these points to see if this study is right for you.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Are you 18 years old or older?
  2. Are you starting AC or cisplatin-based chemotherapy for the first time?
  3. Do you have a general good level of health and activity for someone with your condition?
  4. Do you have any severe heart conditions or uncontrolled diabetes?
  5. Are you pregnant, breastfeeding, or planning to become pregnant during the study?
  6. Have you been in another medical study within the last month?
Answer every question to see your result.

What does participation involve?

If you join this study, you will be in it for about two months. During this time, you'll receive either the new medicine, a dummy medicine (placebo), or standard anti-sickness treatments, along with your regular chemotherapy. You'll have regular check-ups and assessments to see how you're feeling, whether the medicine is working, and to monitor for any side effects. These assessments might include blood tests and discussions about your symptoms. The doctors and nurses will explain everything in detail, and you'll have ongoing support throughout your time in the study.

Potential risks and benefits

Taking part in a study like this could offer potential benefits, such as receiving a new medicine that might be more effective at managing sickness and vomiting from chemotherapy, which could improve your comfort. However, like all medicines, the new treatment might have side effects, and some may be unexpected. There's also a chance that the new medicine might not work for you. You have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Locations (67)

  • Marin Cancer Care
    Verified postcode
    Greenbrae, United States· Recruiting
  • City of Hope Orange County Lennar Foundation Cancer Center
    Verified postcode
    Irvine, United States· Not yet recruiting
  • Cancer and Blood Specialty Clinic
    Verified postcode
    Los Alamitos, United States· Recruiting
  • BASS Cancer Center
    Verified postcode
    Walnut Creek, United States· Recruiting
  • UCHealth Harmony
    Verified postcode
    Fort Collins, United States· Recruiting
  • Clavis Medical
    Verified postcode
    Miami Lakes, United States· Recruiting
  • BRCR Global - Tamarac
    Verified postcode
    Tamarac, United States· Recruiting
  • Summit Cancer Care, PC
    Verified postcode
    Savannah, United States· Recruiting
  • Hope and Healing Cancer Services
    Verified postcode
    Hinsdale, United States· Recruiting
  • Indiana University Health University Hospital
    Verified postcode
    Indianapolis, United States· Not yet recruiting
  • North Mississippi Hematology and Oncology Associates
    Verified postcode
    Tupelo, United States· Recruiting
  • Laura and Isaac Perlmutter Cancer Center
    Verified postcode
    New York, United States· Recruiting

Common questions

What is LY3537021?

It's a new investigational medicine being tested to see if it can help prevent or reduce sickness and vomiting from chemotherapy.

How long will I be in the study?

The study will last for approximately two months from the time you start.

Will I definitely get the new medicine?

Not necessarily. Some participants will receive the new medicine, some a dummy medicine (placebo), and others standard anti-sickness treatments, to compare the effects.

Can I leave the study early?

Yes, you can decide to leave the study at any time, for any reason, and it won't affect your ongoing medical care.

What kind of chemotherapy is this study for?

This study is for people receiving certain types of chemotherapy like 'AC' or cisplatin-based chemotherapy.

How to find out more

Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "A Study to Evaluate LY3537021 for the Treatment of Nausea an…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.